Corvus Pharmaceuticals, Inc. (CRVS) vs Kura Oncology, Inc. (KURA)
Corvus Pharmaceuticals, Inc. and Kura Oncology, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Kura Oncology, Inc. are of similar size ($992.6M and $977.7M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −384.3%) and the lower return on invested capital (−352.5% vs 0.00%). Across the 14 metrics below, Corvus Pharmaceuticals, Inc. leads on 12 and Kura Oncology, Inc. on 2.
Valuation
Profitability
| Metric | CRVS | KURA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.35% | 65.16% |
| Operating margin | 0.00% | (411.90%) | 0.00% |
| Net margin | 0.00% | (384.30%) | 0.00% |
| Free cash flow margin | 0.00% | (152.06%) | 0.00% |
| Return on equity | (18.98%) | (167.71%) | (57.72%) |
| Return on assets | (17.64%) | (46.73%) | (49.22%) |
| Return on invested capital | (352.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack